CDK2 and hepatocellular carcinoma: The overexpression of ZYX significantly increased the levels of PCNA, cyclin D1, CDK2 and CDK4 in the HCC cells, indicating that ZYX promotes the proliferation of HCC cells by accelerating G1/S progression [16–19].